Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria

BackgroundCerebral malaria (CM) is an acute encephalopathy with increased pro-inflammatory cytokines, sequestration of parasitized erythrocytes and localized ischaemia. In children CM induces cognitive impairment in about 10% of the survivors. Erythropoietin (Epo) has – besides of its well known haematopoietic properties – significant anti-inflammatory, antioxidant and anti-apoptotic effects in various brain disorders. The neurobiological responses to exogenously injected Epo during murine CM were examined.MethodsFemale C57BL/6j mice (4–6 weeks), infected with Plasmodium berghei ANKA, were treated with recombinant human Epo (rhEpo; 50–5000 U/kg/OD, i.p.) at different time points. The effect on survival was measured. Brain pathology was investigated by TUNEL (Terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP)-digoxigenin nick end labelling), as a marker of apoptosis. Gene expression in brain tissue was measured by real time PCR.ResultsTreatment with rhEpo increased survival in mice with CM in a dose- and time-dependent manner and reduced apoptotic cell death of neurons as well as the expression of pro-inflammatory cytokines in the brain. This neuroprotective effect appeared to be independent of the haematopoietic effect.ConclusionThese results and its excellent safety profile in humans makes rhEpo a potential candidate for adjunct treatment of CM.

[1]  E. Morishita,et al.  In vivo evidence that erythropoietin protects neurons from ischemic damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Gallini,et al.  Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? , 2000, European Journal of Pediatrics.

[3]  J. Breman,et al.  The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. , 2001, The American journal of tropical medicine and hygiene.

[4]  L. Rénia,et al.  Experimental models of cerebral malaria. , 2005, Current topics in microbiology and immunology.

[5]  W. Jelkmann,et al.  Effects of erythropoietin on brain function. , 2005, Current pharmaceutical biotechnology.

[6]  E. Mackenzie,et al.  A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  M. Koury,et al.  New insights into erythropoiesis , 2002, Current opinion in hematology.

[8]  D. Ribatti,et al.  Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 1999, Blood.

[9]  M. Boivin,et al.  Cognitive Impairment After Cerebral Malaria in Children: A Prospective Study , 2007, Pediatrics.

[10]  W. Cheung,et al.  Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects* , 1998, Clinical pharmacology and therapeutics.

[11]  W. Brück,et al.  Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain , 2001, Acta Neuropathologica.

[12]  S. Masuda,et al.  Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. , 1998, Biochemical and biophysical research communications.

[13]  M. Penkowa,et al.  Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice , 2006, Experimental Neurology.

[14]  M. Buemi,et al.  The Pleiotropic Effects of Erythropoietin in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.

[15]  V. Heussler,et al.  Behavioural and histopathological alterations in mice with cerebral malaria , 2006, Neuropathology and applied neurobiology.

[16]  A. Berger,et al.  Effects of a Combined Therapy of Erythropoietin, Iron, Folate, and Vitamin B12 on the Transfusion Requirements of Extremely Low Birth Weight Infants , 2006, Pediatrics.

[17]  D. Bandyopadhyay,et al.  Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. , 2000, Biochemical pharmacology.

[18]  P. Lewczuk,et al.  Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.

[19]  Kai-Hsin Chang,et al.  Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis. , 2004, The Journal of infectious diseases.

[20]  P. Lewczuk,et al.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Hunt,et al.  Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. , 2003, Trends in immunology.

[22]  A. Buguet,et al.  Recombinant human erythropoietin prevents the death of mice during cerebral malaria. , 2006, The Journal of infectious diseases.

[23]  Charles R. Newton,et al.  Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. , 1998, Pharmacology & therapeutics.

[24]  P Ghezzi,et al.  Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Jelkmann,et al.  Use of recombinant human erythropoietin as an antianemic and performance enhancing drug. , 2000, Current pharmaceutical biotechnology.

[26]  R. Snow,et al.  Host-parasite interaction and morbidity in malaria endemic areas. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[27]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[28]  W. Miller,et al.  Astroglial cytoprotection by erythropoietin pre‐conditioning: implications for ischemic and degenerative CNS disorders , 2005, Journal of neurochemistry.

[29]  P. Ghezzi,et al.  Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis , 2003, The Journal of experimental medicine.

[30]  Kenneth Maiese,et al.  Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases , 2002, Circulation.

[31]  H. Ehrenreich,et al.  The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease , 2006, Journal of neurosurgical anesthesiology.

[32]  T. Taylor,et al.  Cytokine expression in the brain in human cerebral malaria. , 1999, The Journal of infectious diseases.

[33]  S. Juul,et al.  Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. , 2000, Journal of pediatric surgery.

[34]  M. Esiri,et al.  Axonal injury in cerebral malaria. , 2002, The American journal of pathology.

[35]  J. O'brien,et al.  Identification of a neurotrophic sequence in erythropoietin. , 1998, International journal of molecular medicine.

[36]  P. Kaye,et al.  Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria , 2002, The Journal of experimental medicine.

[37]  W. Bubb,et al.  Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  J. Breman,et al.  Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. , 2001, The American journal of tropical medicine and hygiene.

[39]  R. Clark,et al.  To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways , 2003, Progress in Neurobiology.